Myriad Genetics financial statements

미리아드 제네틱스NASDAQ:MYGN · Nasdaq · Healthcare · sector #16
$4.28-6.55%
2026-10-06 close · prelim

Myriad Genetics's published financial data is dated 2026-10-04. 2024 revenue was $838M. 2024 operating profit was −$121M.

Reported results

Myriad Genetics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q